Tag Archives: Pharma
Blissed-Out Fish on Prozac
“According to the USGS, pharmaceutical traces can be found in 80 percent of United States streams.”
Extensive impact of non-antibiotic drugs on human gut bacteria
“we screened more than 1,000 marketed drugs against 40 representative gut bacterial strains, and found that 24% of the drugs with human targets, including members of all therapeutic classes, inhibited the growth of at least one strain in vitro. “
A pharma company that spent $500,000 trying to keep pot illegal just got DEA approval for synthetic marijuana
“Insys Therapeutics, a pharmaceutical company that was one of the chief financial backers of the opposition to marijuana legalization in Arizona last year, received preliminary approval from the Drug Enforcement Administration this week for Syndros, a synthetic marijuana drug.”
Highest grossing pharmaceuticals don’t help majority of patients
” The top ten highest-grossing drugs in the United States help between 1 in 25 and 1 in 4 of the people who take them…”
Most off-label antidepressant prescriptions lack strong scientific evidence
Most off-label antidepressant prescriptions lack strong scientific evidence, finds a study published by The BMJ today.
Medical Studies Often Leave Out Adverse Outcomes
“Approximately half of studies published on new medical treatments leave out at least some of the adverse effects they uncovered, according to a recent analysis in PLOS Medicine.”
Big Pharma’s Manufactured Epidemic: The Misdiagnosis of ADHD
“This was all orchestrated behind the sheen of academic institutions—it’s easy to get away with it when the doctors performing the studies have affiliations at Harvard, Johns Hopkins and Cal, with only tiny print indicating that their work was subsidized by the drug makers and rewarded with consulting and speaking contracts.”
Pharma Company Funding Anti-Pot Fight Worried About Losing Business, Filings Show
“Pharmaceutical executives who recently made a major donation to an anti-marijuana legalization campaign claimed they were doing so out of concern for the safety of children — but their investor filings reveal that pot poses a direct threat to their plans to cash in on a synthetic cannabis product they have developed.”
One striking chart shows why pharma companies are fighting legal marijuana
“Our findings and existing clinical literature imply that patients respond to medical marijuana legislation as if there are clinical benefits to the drug, which adds to the growing body of evidence suggesting that the Schedule 1 status of marijuana is outdated,” the study concludes.”